Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds.
BMJ. 2020 07 01; 370:m2650.BMJ

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Griffin S

London.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32611587

Citation

Griffin, Shaun. "Covid-19: Lopinavir-ritonavir Does Not Benefit Hospitalised Patients, UK Trial Finds." BMJ (Clinical Research Ed.), vol. 370, 2020, pp. m2650.

Griffin S. Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. BMJ. 2020;370:m2650.

Griffin, S. (2020). Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. BMJ (Clinical Research Ed.), 370, m2650. https://doi.org/10.1136/bmj.m2650

Griffin S. Covid-19: Lopinavir-ritonavir Does Not Benefit Hospitalised Patients, UK Trial Finds. BMJ. 2020 07 1;370:m2650. PubMed PMID: 32611587.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. A1 - Griffin,Shaun, Y1 - 2020/07/01/ PY - 2020/7/3/entrez PY - 2020/7/3/pubmed PY - 2020/7/3/medline SP - m2650 EP - m2650 JF - BMJ (Clinical research ed.) JO - BMJ VL - 370 SN - 1756-1833 UR - https://www.unboundmedicine.com/medline/citation/32611587/Covid_19:_Lopinavir_ritonavir_does_not_benefit_hospitalised_patients_UK_trial_finds_ DB - PRIME DP - Unbound Medicine ER -

Tags

Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds.BMJ. 2020 07 01; 370:m2650.BMJ